# Drug to Drug Interaction Study With ASP1941 and Metformin

> **NCT01302145** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 36 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** ASP1941
- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01302145
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02-25
- **Primary completion:** 2009-12-09
- **Final completion:** 2009-12-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01302145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01302145, "Drug to Drug Interaction Study With ASP1941 and Metformin". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01302145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*